Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic GHDx Entry last modified on: Mar 14, 2022
Spain Prevalence of Depression, Before and After the Covid-19 Pandemic 2020 GHDx Entry last modified on: Oct 10, 2022
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline GHDx Entry last modified on: May 12, 2022
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 GHDx Entry last modified on: May 12, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries? GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020 GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors GHDx Entry last modified on: May 12, 2022
Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing GHDx Entry last modified on: Apr 10, 2023
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia. Preprint GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada GHDx Entry last modified on: Mar 14, 2022
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020 GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset GHDx Entry last modified on: Mar 14, 2022
Safe Perinatal Management of Neonates Born to SARS-CoV-2 Positive Mothers at the Epicenter of the Italian Epidemic GHDx Entry last modified on: Apr 10, 2023
Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study GHDx Entry last modified on: Mar 22, 2024
Sex differences in clinical characteristics of migraine and its burden: a population-based study GHDx Entry last modified on: Mar 22, 2024
School bullying associated suicidal risk in children and adolescents from Yunnan, China: The mediation of social support GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1) GHDx Entry last modified on: Jun 17, 2021
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020 GHDx Entry last modified on: May 12, 2022
SARS-CoV-2-Specific Antibody Prevalence and Symptoms in a Local Austrian Population GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study. Preprint GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19 GHDx Entry last modified on: Jan 31, 2024
Systematic screening for SARS-CoV-2 in pregnant women admitted for delivery in a Portuguese maternity GHDx Entry last modified on: Apr 10, 2023
Symptom Burden among Older COVID-19 Survivors Two Years after Hospital Discharge GHDx Entry last modified on: Mar 22, 2024
Surveillance and epidemiological characterization of human adenovirus infections among outpatient children with acute gastroenteritis during the COVID-19 epidemic in Shanghai, China GHDx Entry last modified on: Oct 23, 2024
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint Cross-sectional GHDx Entry last modified on: May 12, 2022
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint GHDx Entry last modified on: Sep 21, 2021
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. Preprint GHDx Entry last modified on: Dec 20, 2023
SARS-CoV-2 Infection During Pregnancy and Associated Perinatal Health Outcomes: A National US Cohort Study GHDx Entry last modified on: Apr 10, 2023
Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study GHDx Entry last modified on: Dec 12, 2023
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco. Preprint GHDx Entry last modified on: Mar 14, 2022
Serial household serosurvey for COVID-19 in low and high transmission neighborhoods of urban Pakistan. Preprint Cross-sectional GHDx Entry last modified on: Mar 14, 2022
Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019 GHDx Entry last modified on: Jan 31, 2024